Rana K Zabad

Phone402-559-9953

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Rana K Zabad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

977 Citations
16 h-Index
27 Article
4 Review article
2 Letter
1 Comment/debate

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Cree, B. A. C., Cutter, G., Wolinsky, J. S., Freedman, M. S., Comi, G., Giovannoni, G., Hartung, H. P., Arnold, D., Kuhle, J., Block, V., Munschauer, F. E., Sedel, F., Lublin, F. D., Reingold, S., Duquette, P., Derfuss, T., Fazekas, F., Sormani, M. P., Lisak, R. P., Graves, J. & 94 others, Krieger, S., Zabad, R. K., Newsome, S., Barton, J., MacDonell, R., Marriott, M., De Klippel, N., Laureys, G., Willekens, B., Devonshire, V., Freedman, M., Girard, J. M., Giacomini, P., McKelvey, R., Selchen, D., Vorobeychik, G., Witkowski, L., Ampapa, R., Preiningerova, J. L., Meluzinova, E., Talab, R., Vachova, M., Aktas, O., Buttmann, M., Birte, E. H., Kuempfel, T., Friedemann, P., Rau, D., Reifschneider, G., Sokolowski, P., Tumani, H., Satori, M., Pozzilli, C., Klosek, A., Koscielniak, J., Waldemar, F., Zajda, M., Gonzalez, R. A., Ayuso, G. I., Sanchez, V. F., Guevara, C. O., Rodriguez, J. E. M., Montalban, X., Ramio-Torrenta, L., Brundin, L., Lycke, J., Terzi, M., Guadagno, J., Mahad, D., Pace, A., Schmierer, K., Toosy, A., Webb, S., Agius, M., Amezcua, L., Apperson, M., Bagert, B., Bandari, D., Bernitsas, E., Calkwood, J., Carter, J., Cohen, B., Conway, D., Cooper, J., Corboy, J., Coyle, P., Cree, B., Freedman, M., Ford, C., Fox, E., Goldman, M., Greenberg, B., Kita, M., Leist, T., Lynch, S., Miller, A., Moses, H., Naismith, R., Picone, M. A., Perminder, B., Rae-Grant, A., Rammohan, K., Reder, A., Riley, C., Robertson, D., Rowe, V., Saidha, S., Samkoff, L., Severson, C., Smoot, K., Stoll, S., Trudell, R., Weinstock-Guttman, B. & Yathiraj, S., Dec 2020, In: The Lancet Neurology. 19, 12, p. 988-997 10 p.
Research output: Contribution to journal › Article › peer-review
31 Scopus citations
Sex effects across the lifespan in women with multiple sclerosis
Krysko, K. M., Graves, J. S., Dobson, R., Altintas, A., Amato, M. P., Bernard, J., Bonavita, S., Bove, R., Cavalla, P., Clerico, M., Corona, T., Doshi, A., Fragoso, Y., Jacobs, D., Jokubaitis, V., Landi, D., Llamosa, G., Longbrake, E. E., Maillart, E., Marta, M. & 10 others, Midaglia, L., Shah, S., Tintore, M., van der Walt, A., Voskuhl, R., Wang, Y., Zabad, R. K., Zeydan, B., Houtchens, M. & Hellwig, K., 2020, In: Therapeutic Advances in Neurological Disorders. 13
Research output: Contribution to journal › Review article › peer-review

Open Access
17 Scopus citations
Multiple Sclerosis at Home Access (MAHA): An initiative to improve care in the community
Healey, K., Zabad, R., Young, L., Lindner, A., Lenz, N., Stewart, R. & Charlton, M., May 1 2019, In: International Journal of MS Care. 21, 3, p. 101-112 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Scopus citations
Overlapping demyelinating syndrome and anti-N-methyl-D-aspartate receptor encephalitis with seizures
Taraschenko, O. & Zabad, R., 2019, In: Epilepsy and Behavior Reports. 12, 100338.
Research output: Contribution to journal › Article › peer-review

Open Access
14 Scopus citations
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
ASCEND investigators, May 2018, In: The Lancet Neurology. 17, 5, p. 405-415 11 p.
Research output: Contribution to journal › Article › peer-review
137 Scopus citations

Rana K Zabad, MD

Fingerprint

Network

Dive into details

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Sex effects across the lifespan in women with multiple sclerosis

Multiple Sclerosis at Home Access (MAHA): An initiative to improve care in the community

Overlapping demyelinating syndrome and anti-N-methyl-D-aspartate receptor encephalitis with seizures

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Rana K Zabad, MD

Fingerprint

Network

Research output

Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial

Sex effects across the lifespan in women with multiple sclerosis

Multiple Sclerosis at Home Access (MAHA): An initiative to improve care in the community

Overlapping demyelinating syndrome and anti-N-methyl-D-aspartate receptor encephalitis with seizures

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension